Search Results - Wendy Stock

Refine Results
  1. 1

    Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients by Caner Saygin, Joseph Cannova, Wendy Stock, Lori Muffly

    Published in Haematologica (2022-12-01)
    Get full text
    Article


  2. 2

    Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL) by Martin Mutonga, Kenji Tamura, Gregory Malnassy, Noreen Fulton, Amanda de Albuquerque, Ryuji Hamamoto, Wendy Stock, Yusuke Nakamura, Houda Alachkar

    Published in Translational Oncology (2015-10-01)
    Get full text
    Article


  3. 3

    Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy by Guanghao Liang, Linchen Wang, Qiancheng You, Kirk Cahill, Chuanyuan Chen, Wei Zhang, Noreen Fulton, Wendy Stock, Olatoyosi Odenike, Chuan He, Dali Han

    Published in Advanced Science (2023-08-01)
    Get full text
    Article


  4. 4

    Clinical use of measurable residual disease in adult ALL: recommendations from a panel of US experts by Nicholas J. Short, Ibrahim Aldoss, Daniel J. DeAngelo, Marina Konopleva, Jessica Leonard, Aaron C. Logan, Jae Park, Bijal Shah, Wendy Stock, Elias Jabbour

    Published in Blood Advances (2025-03-01)
    Get full text
    Article


  5. 5

    Pediatric-inspired regimens and HSCT for adolescents and young adults with acute lymphoblastic leukemia by Yuliia Sereda, Htun Ja Mai, Ghid Kanaan, John W. Melson, Teruhiko Terasawa, Matthew C. Cheung, Wendy Stock, Julie A. Wolfson, Ian J. Saldanha, Ethan M. Balk

    Published in Blood Advances (2026-05-01)
    Get full text
    Article


  6. 6

    CD58 expression does not impact response to inotuzumab ozogamicin in patients with B‐cell acute lymphoblastic leukemia by Rafael Madero‐Marroquin, Ryan W. Hunter, Caner Saygin, Hannah Johnston, Adam S. DuVall, Hamed Rahmani Youshanlouei, Clinton Osei, Syed Shah, Wendy Stock, Sandeep Gurbuxani, Anand A. Patel

    Published in eJHaem (2025-02-01)
    Get full text
    Article


  7. 7

    Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909 by Hongtao Liu, Jeffrey L. Johnson, Greg Koval, Greg Malnassy, Dorie Sher, Lloyd E. Damon, Eric D. Hsi, Donna Marie Bucci, Charles A. Linker, Bruce D. Cheson, Wendy Stock

    Published in Haematologica (2012-04-01)
    Get full text
    Article


  8. 8

    Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients by Lori S. Muffly, Masha Kocherginsky, Wendy Stock, Quynh Chu, Michael R. Bishop, Lucy A. Godley, Justin Kline, Hongtao Liu, Olatoyosi M. Odenike, Richard A. Larson, Koen van Besien, Andrew S. Artz

    Published in Haematologica (2014-08-01)
    Get full text
    Article


  9. 9

    WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia by Hongtao Liu, Yuanyuan Zha, Noura Choudhury, Gregory Malnassy, Noreen Fulton, Margaret Green, Jae-Hyun Park, Yusuke Nakamura, Richard A. Larson, Andres M. Salazar, Olatoyosi Odenike, Thomas F. Gajewski, Wendy Stock

    Published in Experimental Hematology & Oncology (2018-01-01)
    Get full text
    Article


  10. 10

    Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the firs... by Yun Fan, Andrew S. Artz, Koen van Besien, Wendy Stock, Richard A. Larson, Olatoyosi Odenike, Lucy A. Godley, Justin Kline, John M. Cunningham, James L. LaBelle, Michael R. Bishop, Hongtao Liu

    Published in Experimental Hematology & Oncology (2019-01-01)
    Get full text
    Article


  11. 11

    Efficacy and tolerability of a modified pediatric‐inspired intensive regimen for acute lymphoblastic leukemia in older adults by Anand Ashwin Patel, Joseph Heng, Emily Dworkin, Sarah Monick, Benjamin A. Derman, Adam S. DuVall, Sandeep Gurbuxani, Satyajit Kosuri, Hongtao Liu, Michael Thirman, Lucy A. Godley, Olatoyosi Odenike, Richard A. Larson, Wendy Stock

    Published in eJHaem (2021-08-01)
    Get full text
    Article


  12. 12

    Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study by Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani

    Published in Blood Advances (2017-06-01)
    Get full text
    Article


  13. 13

    Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure... by Kellie J. Archer, Han Fu, Krzysztof Mrózek, Deedra Nicolet, Alice S. Mims, Geoffrey L. Uy, Wendy Stock, John C. Byrd, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Klaus H. Metzeler, Tobias Herold, Ann-Kathrin Eisfeld

    Published in Journal of Hematology & Oncology (2024-05-01)
    Get full text
    Article


  14. 14

    S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA... by Matthew Wieduwilt, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Ken Byrd, Kimberly Doucette, James Mangan, Gregory Masters, Alice Mims, Katarzyna Jamieson, Shira Dinner, Ali Bseiso, Geoffrey Uy, Harry Erba, Mark Litzow, Richard Stone

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  15. 15

    P561: REVUMENIB IN PATIENTS WITH ACUTE LEUKEMIAS: COMPASSIONATE USE PROGRAM EXPERIENCE by Jeffrey Rubnitz, Ghayas C. Issa, Eytan M. Stein, Neerav Shukla, Wendy Stock, Andrius Žučenka, Sajad Khazal, Nandita Khera, Elliot Stieglitz, Jeremy Rubinstein, Galit Rosen, Rachel Ghiraldi, Huy Van Nguyen, Nicole Mcneer, C. Michel Zwaan

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  16. 16

    P550: INFLUENCE OF RACE ON COMPLICATIONS OF INTENSIVE CHEMOTHERAPY IN AML by Ivy Abraham, Garth Rauscher, Anand Patel, Sarah Monick, Madelyn Burkart, Ami Dave, Vedavyas Gannamani, Amani Erra, Ahmed Aleem, Nepheli Raptis, Matthew Kroll, Maryam Zia, Stephanie Tsai, Melissa Larson, Wendy Stock, Jessica Altman, Irum Khan

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  17. 17

    Autologous transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia achieves outcomes similar to allogeneic transplantation: results of CALGB Study 10001 (... by Meir Wetzler, Dorothy Watson, Wendy Stock, Gregory Koval, Flora A. Mulkey, Eva E. Hoke, John M. McCarty, William G. Blum, Bayard L. Powell, Guido Marcucci, Clara D. Bloomfield, Charles A. Linker, Richard A. Larson

    Published in Haematologica (2014-01-01)
    Get full text
    Article


  18. 18

    Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy by Rafael Madero‐Marroquin, Joseph Cannova, Emily Dworkin, Austin Wesevich, Gregory W. Roloff, Caner Saygin, Mariam T. Nawas, Adam S. DuVall, Satyajit Kosuri, Michael J. Thirman, Olatoyosi Odenike, Wendy Stock, Richard A. Larson, Michael W. Drazer, Anand A. Patel

    Published in eJHaem (2025-06-01)
    Get full text
    Article


  19. 19

    Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival by Koen van Besien, Parameswaran Hari, Mei-Jie Zhang, Hong-Tao Liu, Wendy Stock, Lucy Godley, Olatoyosi Odenike, Richard Larson, Michael Bishop, Amittha Wickrema, Usama Gergis, Sebastian Mayer, Tsiporah Shore, Stephanie Tsai, Joanna Rhodes, Melissa M. Cushing, Sandra Korman, Andrew Artz

    Published in Haematologica (2016-05-01)
    Get full text
    Article


  20. 20

    Real-world performance of the CALGB 10403 regimen in young adults in the United States by Brandon DaSilva, Alicia Darwin, Amy Zhang, Rutu D. Vyas, Kathryn Russell, Jason S. Gilbert, Virginia Tan, Susan Feldt, Hannah Johnston, Emily C. Liang, Adam S. DuVall, Michaela Liedtke, Wendy Stock, Ryan D. Cassaday, Marc Schwartz, Jessica T. Leonard, Lori S. Muffly, Marlise R. Luskin

    Published in Blood Neoplasia (2025-08-01)
    Get full text
    Article


Search Tools: